|
US5780222A
(en)
|
1995-04-10 |
1998-07-14 |
Alpha Therapeutic Corporation |
Method of PCR testing of pooled blood samples
|
|
JP2001503396A
(ja)
*
|
1996-10-11 |
2001-03-13 |
アルザ コーポレイション |
治療用リポソーム組成物および方法
|
|
US20050025819A1
(en)
*
|
1997-07-14 |
2005-02-03 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
|
US20020115609A1
(en)
*
|
1997-07-14 |
2002-08-22 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
|
US6372720B1
(en)
|
1998-02-05 |
2002-04-16 |
Kenneth J. Longmuir |
Liposome fusion and delivery vehicle
|
|
US6406693B1
(en)
|
1998-07-13 |
2002-06-18 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using antibodies to aminophospholipids
|
|
US6312694B1
(en)
*
|
1998-07-13 |
2001-11-06 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
|
|
US6818213B1
(en)
|
1998-07-13 |
2004-11-16 |
Board Of Regents, The University Of Texas System |
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
|
|
ES2533255T3
(es)
*
|
1998-07-13 |
2015-04-08 |
Board Of Regents, The University Of Texas System |
Utilización de anticuerpos anti-aminofosfolípidos para el tratamiento del cáncer
|
|
US6379698B1
(en)
*
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
|
CA2370690A1
(en)
*
|
1999-04-20 |
2000-10-26 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
US7303760B2
(en)
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
|
CA2369595C
(en)
|
1999-04-23 |
2010-10-05 |
Alza Corporation |
Conjugate having a cleavable linkage for use in a liposome
|
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
AUPQ014699A0
(en)
*
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
WO2001041738A2
(en)
*
|
1999-12-10 |
2001-06-14 |
Celator Technologies Inc. |
Lipid carrier compositions with protected surface reactive functions
|
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
|
WO2002036073A2
(en)
*
|
2000-11-02 |
2002-05-10 |
Smithkline Beecham Corporation |
Receptor antagonist-lipid conjugates and delivery vehicles containing same
|
|
JP2004521109A
(ja)
*
|
2001-01-17 |
2004-07-15 |
ザイコス インク． |
核酸輸送用製剤
|
|
IL158160A0
(en)
*
|
2001-03-26 |
2004-03-28 |
Alza Corp |
Liposome composition for improved intracellular delivery of a therapeutic agent
|
|
WO2002078672A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Alza Corporation |
Liposomal tumor necrosis factor compositions and methods
|
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
|
US20030157030A1
(en)
|
2001-11-02 |
2003-08-21 |
Insert Therapeutics, Inc. |
Methods and compositions for therapeutic use of rna interference
|
|
US20040219201A1
(en)
*
|
2001-12-06 |
2004-11-04 |
Yechezkel Barenholz |
Tempamine compositions and methods of use
|
|
US20040147466A1
(en)
*
|
2002-01-17 |
2004-07-29 |
Barman Shikha P. |
Nucleic acid delivery formulations
|
|
DE10207178A1
(de)
*
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
DK1530482T3
(da)
|
2002-07-18 |
2014-01-20 |
Helix Biopharma Corp |
Brug af urease til at hæmme vækst af cancerceller
|
|
US20040161468A1
(en)
*
|
2002-12-04 |
2004-08-19 |
L'oreal |
Stabilization of aromatic active principles using aromatic polymers
|
|
FR2848101B1
(fr)
*
|
2002-12-04 |
2006-08-11 |
Oreal |
Procede de traitement cosmetique des matieres keratiniques impliquant la liberation controlee de principes actifs aromatiques a partir de particules de polymere aromatique
|
|
CA2510780A1
(en)
*
|
2002-12-19 |
2004-07-08 |
Alza Corporation |
Method of treating angiogenic tissue growth
|
|
EP2260874A1
(en)
|
2003-01-06 |
2010-12-15 |
Angiochem Inc. |
Aprotinin analogs as carriers across the blood-brain barrier
|
|
US20060198882A1
(en)
*
|
2003-03-21 |
2006-09-07 |
Yechezkel Barenholz |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
|
US8846079B1
(en)
|
2004-12-01 |
2014-09-30 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
|
US20060115523A1
(en)
*
|
2004-12-01 |
2006-06-01 |
Konduri Kameswari S |
Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
|
|
US11324698B2
(en)
|
2003-08-28 |
2022-05-10 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
|
IL158599A0
(en)
*
|
2003-10-26 |
2004-05-12 |
Yeda Res & Dev |
Methods of modulating hematopoiesis
|
|
EP1691780A2
(en)
*
|
2003-11-21 |
2006-08-23 |
Alza Corporation |
Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
|
|
US7208174B2
(en)
*
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
|
DK1737487T3
(en)
*
|
2004-03-30 |
2016-08-22 |
Canadian Blood Services |
Process for the treatment of autoimmune diseases with antibodies
|
|
CA2562527A1
(en)
*
|
2004-04-21 |
2005-11-10 |
Alza Corporation |
Polymer conjugate releasable under mild thiolytic conditions
|
|
US7608579B2
(en)
*
|
2004-06-16 |
2009-10-27 |
Pneumrx, Inc. |
Lung volume reduction using glue compositions
|
|
US20050281739A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue using compositions
|
|
US7553810B2
(en)
*
|
2004-06-16 |
2009-06-30 |
Pneumrx, Inc. |
Lung volume reduction using glue composition
|
|
US20050281798A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting sites of damaged lung tissue using composition
|
|
US20050281740A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
|
US20050281799A1
(en)
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting damaged lung tissue using compositions
|
|
US7678767B2
(en)
|
2004-06-16 |
2010-03-16 |
Pneumrx, Inc. |
Glue compositions for lung volume reduction
|
|
WO2006014567A2
(en)
*
|
2004-07-08 |
2006-02-09 |
Pneumrx, Inc. |
Pleural effusion treatment device, method and material
|
|
EP1793805A1
(en)
*
|
2004-09-09 |
2007-06-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions
|
|
CA2579695A1
(en)
*
|
2004-09-09 |
2006-03-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Liposomal compositions of glucocorticoid and glucocorticoid derivatives
|
|
US6998028B1
(en)
*
|
2004-09-24 |
2006-02-14 |
Superpower, Inc. |
Methods for forming superconducting conductors
|
|
TW200612993A
(en)
*
|
2004-10-08 |
2006-05-01 |
Alza Corp |
Lipopolymer conjugates
|
|
TW200618820A
(en)
*
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
WO2006051549A2
(en)
*
|
2004-11-15 |
2006-05-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination therapy associating preferably a ceramide with a cytotoxic drug
|
|
US20090016959A1
(en)
*
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
|
CA2597958C
(en)
*
|
2005-02-18 |
2019-01-15 |
Angiochem Inc. |
Molecules for transporting a compound across the blood-brain barrier
|
|
WO2007005754A2
(en)
*
|
2005-07-01 |
2007-01-11 |
Alza Corporation |
Liposomal delivery vehicle for hydrophobic drugs
|
|
JP5436856B2
(ja)
|
2005-07-15 |
2014-03-05 |
アンジオケム インコーポレーティッド |
薬学的複合体における担体としてのアプロチニンポリペプチドの使用
|
|
US20070055200A1
(en)
*
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Needle-free jet injection drug delivery device
|
|
JP5178520B2
(ja)
|
2005-09-22 |
2013-04-10 |
メディバス エルエルシー |
固体ポリマー送達組成物およびその使用法
|
|
JP5192384B2
(ja)
|
2005-09-22 |
2013-05-08 |
メディバス エルエルシー |
ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
|
|
EP1929073A4
(en)
*
|
2005-09-27 |
2010-03-10 |
Amunix Inc |
PROTEIN MEDICAMENT AND ITS USE
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
EP1962796A2
(en)
*
|
2005-12-08 |
2008-09-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods for affecting liposome composition by ultrasound irradiation
|
|
US8067380B2
(en)
|
2005-12-19 |
2011-11-29 |
Industrial Technology Research Institute |
Glutathione-based delivery system
|
|
US7446096B2
(en)
*
|
2005-12-19 |
2008-11-04 |
Industrial Technology Research Institute |
Glutathione based delivery system
|
|
US20070190127A1
(en)
|
2005-12-30 |
2007-08-16 |
Mingdong Zhou |
Extended release of neuregulin for improved cardiac function
|
|
US8597636B2
(en)
*
|
2006-01-13 |
2013-12-03 |
Canadian Blood Services |
Method for treating autoimmune diseases and compositions therefor
|
|
US20070218116A1
(en)
*
|
2006-03-14 |
2007-09-20 |
Schwendener Reto A |
Compositions and methods for the treatment of tumors and tumor metastases
|
|
DE102007004303A1
(de)
*
|
2006-08-04 |
2008-02-07 |
Osram Opto Semiconductors Gmbh |
Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
|
|
WO2008105917A2
(en)
*
|
2006-08-14 |
2008-09-04 |
Rensselaer Polytechnic Institute |
Polyvalent inhibitors of pathogens
|
|
EP2058009A4
(en)
*
|
2006-08-31 |
2009-10-28 |
Astellas Pharma Inc |
REVERSE TARGETING-lipid vesicles
|
|
US20100297218A1
(en)
*
|
2006-09-20 |
2010-11-25 |
Pneumrx, Inc. |
Tissue adhesive compositions and methods thereof
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
US20100210575A1
(en)
*
|
2007-06-29 |
2010-08-19 |
Wisconsin Alumni Research Foundation |
Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
|
|
CA2695374A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
|
AU2008298592A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
|
CA2700378A1
(en)
*
|
2007-09-21 |
2009-03-29 |
Cytimmune Sciences, Inc. |
Nanotherapeutic colloidal metal compositions and methods
|
|
US10365224B2
(en)
|
2007-12-06 |
2019-07-30 |
Genalyte, Inc. |
Label-free optical sensors
|
|
DK2279008T3
(en)
*
|
2008-04-18 |
2019-04-29 |
Angiochem Inc |
PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED PROCEDURES FOR PREPARATION AND USE
|
|
US8231895B2
(en)
|
2008-05-22 |
2012-07-31 |
Universidade De Coimbra |
Targeted delivery to human diseases and disorders
|
|
US8239357B1
(en)
*
|
2008-09-12 |
2012-08-07 |
Ryan, LLC |
Method and system for extracting information from electronic data sources
|
|
CN102245642A
(zh)
|
2008-10-15 |
2011-11-16 |
安吉奥开米公司 |
Glp-1激动剂的结合物及其用途
|
|
JP5705118B2
(ja)
|
2008-10-15 |
2015-04-22 |
アンジオケム インコーポレーテッド |
薬物送達のためのエトポシドおよびドキソルビシン複合体
|
|
ES2939310T3
(es)
|
2008-10-27 |
2023-04-20 |
Genalyte Inc |
Biosensores basados en sondeo y detección ópticos
|
|
WO2010063122A1
(en)
*
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
CA2747220A1
(en)
|
2008-12-17 |
2010-06-24 |
Richard Beliveau |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
|
JP2012515201A
(ja)
*
|
2009-01-15 |
2012-07-05 |
ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム |
改変された生分解速度論を有する多孔性構造
|
|
CN108530543B
(zh)
|
2009-02-03 |
2023-06-23 |
阿穆尼克斯制药公司 |
延伸重组多肽和包含该延伸重组多肽的组合物
|
|
DE102009012640A1
(de)
*
|
2009-03-09 |
2010-09-30 |
Freie Universität Berlin |
Mit einer Phosphoamidatgruppe modifizierte Verbindung und deren Verwendung
|
|
CN102510759A
(zh)
|
2009-04-20 |
2012-06-20 |
安吉奥开米公司 |
利用与血管肽-2类似物结合的抗癌剂治疗卵巢癌
|
|
CN103140236B
(zh)
|
2009-06-08 |
2017-04-19 |
阿穆尼克斯运营公司 |
生长激素多肽及其制备和使用方法
|
|
EP2440228B8
(en)
|
2009-06-08 |
2023-02-22 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
US20120100206A1
(en)
|
2009-06-11 |
2012-04-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
|
JP5932642B2
(ja)
|
2009-07-02 |
2016-06-08 |
アンジオケム インコーポレーテッド |
多量体ペプチドコンジュゲートおよびその使用
|
|
US9062299B2
(en)
|
2009-08-24 |
2015-06-23 |
Amunix Operating Inc. |
Coagulation factor IX compositions and methods of making and using same
|
|
JP2013509422A
(ja)
|
2009-10-30 |
2013-03-14 |
シーエヌエス セラピューティクス，インク． |
改良されたニュールツリン分子
|
|
TWI397428B
(zh)
*
|
2009-12-29 |
2013-06-01 |
Ind Tech Res Inst |
標的第四介白素受體之傳輸系統
|
|
WO2011092708A2
(en)
|
2010-02-01 |
2011-08-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Liposomes comprising amphipathic drugs and method for their preparation
|
|
EP3266881B1
(en)
|
2010-11-05 |
2019-12-25 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
|
CN103748139B
(zh)
|
2011-06-23 |
2016-08-17 |
帝斯曼知识产权资产管理有限公司 |
用于递送生物活性剂的包含生物可降解的聚酯酰胺共聚物的微米颗粒或纳米颗粒
|
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
|
HUE051570T2
(hu)
|
2011-07-13 |
2021-03-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Liposzómák biszfoszfonát és amfipatikus szer együtt kapszulázásához
|
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
|
BR112014019901A8
(pt)
|
2012-02-15 |
2018-01-02 |
Biogen Idec Inc |
Proteínas de fator viii recombinante
|
|
EP3564260B1
(en)
|
2012-02-15 |
2022-10-19 |
Bioverativ Therapeutics Inc. |
Factor viii compositions and methods of making and using same
|
|
US20130261010A1
(en)
|
2012-03-12 |
2013-10-03 |
The Board Of Trustees Of The University Of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of use
|
|
CA2869674A1
(en)
|
2012-06-08 |
2013-12-12 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
CN102920658B
(zh)
*
|
2012-11-02 |
2015-01-21 |
艾韦特(溧阳)医药科技有限公司 |
与glp-1类似物和聚乙二醇结合的脂质体及其制备方法
|
|
TWI667255B
(zh)
|
2013-08-14 |
2019-08-01 |
美商生物化學醫療公司 |
因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
|
|
CA2930665A1
(en)
|
2013-11-18 |
2015-05-21 |
Rubius Therapeutics, Inc. |
Synthetic membrane-receiver complexes
|
|
CN107124869B
(zh)
|
2014-03-25 |
2022-04-01 |
美国政府陆军部 |
包含含有单磷酰脂质a（mpla）的脂质体组合物和皂苷的无毒佐剂制剂
|
|
US20170173005A1
(en)
|
2014-03-27 |
2017-06-22 |
Research Foundation Of The City University Of New York |
Method for detecting or treating triple negative breast cancer
|
|
PL3125927T3
(pl)
|
2014-04-01 |
2021-07-19 |
Rubius Therapeutics, Inc. |
Sposoby i kompozycje do immunomodulacji
|
|
JP6720447B2
(ja)
|
2014-12-18 |
2020-07-08 |
ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． |
酸感受性薬剤の送達のための薬剤送達系
|
|
BR112017015582A2
(pt)
|
2015-01-23 |
2018-03-13 |
Helix Biopharma Corp |
conjugados de anticorpo-urease para propósitos terapêuticos
|
|
US20180071253A1
(en)
|
2015-03-17 |
2018-03-15 |
Lipomedix Pharmaceuticals Ltd. |
Methods for the treatment of bladder cancer
|
|
JP6823055B2
(ja)
|
2015-06-15 |
2021-01-27 |
アンジオケム インコーポレーテッド |
軟髄膜癌腫症の治療方法
|
|
IL257231B
(en)
|
2015-08-03 |
2022-09-01 |
Bioverativ Therapeutics Inc |
Factor ix fusion proteins and methods of making and using same
|
|
CA2997286A1
(en)
|
2015-09-14 |
2017-03-23 |
Vgsk Technologies, Inc. |
A sterically stabilized carrier for subcutaneous, sublingual and oral therapeutics, compositions and methods for treating a mammal
|
|
IL286493B
(en)
|
2015-11-06 |
2022-07-01 |
Memorial Sloan Kettering Cancer Center |
Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
|
|
EP3548066A1
(en)
|
2016-12-02 |
2019-10-09 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilic arthropathy using chimeric clotting factors
|
|
US11260132B2
(en)
|
2017-03-16 |
2022-03-01 |
Children's Medical Center Corporation |
Engineered liposomes as cancer-targeted therapeutics
|
|
AU2018350887A1
(en)
|
2017-10-16 |
2020-03-05 |
Adjuvance Technologies, Inc. |
Triterpene saponin analogues
|
|
HRP20250709T1
(hr)
|
2018-05-18 |
2025-08-15 |
Bioverativ Therapeutics Inc. |
Postupci liječenja hemofilije a
|
|
JP2020026397A
(ja)
*
|
2018-08-09 |
2020-02-20 |
国立大学法人 岡山大学 |
ＴｒｋＢアンタゴニストを含む医薬組成物
|
|
BR112022026420A2
(pt)
|
2020-06-25 |
2023-04-18 |
Amunix Pharmaceuticals Inc |
Composições biespecíficas direcionadas por her-2 e métodos para preparar e usar as mesmas
|
|
BR112023018768A2
(pt)
|
2021-03-24 |
2023-11-28 |
Alkermes Inc |
Anticorpos de upar e proteínas de fusão com os mesmos
|
|
WO2022235907A1
(en)
|
2021-05-05 |
2022-11-10 |
Vgsk Technologies, Inc. |
Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation
|
|
KR20240159001A
(ko)
|
2022-03-14 |
2024-11-05 |
화이자 인코포레이티드 |
보조제의 제조 방법
|
|
KR20250113501A
(ko)
|
2022-12-01 |
2025-07-25 |
화이자 인코포레이티드 |
폐렴구균 접합체 백신 제형
|
|
WO2025057058A1
(en)
|
2023-09-13 |
2025-03-20 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
WO2025191415A1
(en)
|
2024-03-11 |
2025-09-18 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
|